Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in PROTAGONIST THERAPEUTICS INC
BNP PARIBAS FINANCIAL MARKETS holds 97,764 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $8.5M as of 2025-Q4. The position was increased (++644.2% shares). PTGX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$8.5M
Current Shares
97,764
Total Value Change
+$8.4M
Total Shares Change
+94,067
Other major holders of PTGX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A., BlackRock, Inc.
Increased |
| 97,764 |
+644.2% |
| $8.5M |
| 0.0% |
| $87.26 |
44 |
| 2025-Q3 | Increased | 13,137 | +43.8% | $872,691 | 0.0% | $65.14 | 34 |
| 2025-Q2 | Decreased | 9,139 | -35.5% | $505,113 | 0.0% | $55.69 | 0 |
| 2025-Q1 | Decreased | 14,169 | -27.2% | $685,213 | 0.0% | $48.88 | 0 |
| 2024-Q4 | Decreased | 19,465 | -4.1% | $751,349 | 0.0% | $38.51 | 0 |
| 2024-Q3 | Increased | 20,294 | +448.9% | $913,230 | 0.0% | $44.56 | 40 |
| 2024-Q2 | Decreased | 3,697 | -92.2% | $128,101 | 0.0% | $34.65 | 0 |